• 1971

    Whatman Biochemicals founded as a joint venture between Whatman and the Biochemical Engineering Department at University College London to develop enzymes for the clinical diagnostics market

  • 1972

    First fermentation production plant opened at Springfield Mill, Maidstone, UK

  • 1980


    Whatman Biochemicals wins Queen’s Award for export

  • 1981


    Founding of Genzyme Biochemicals Ltd. Whatman Biochemicals acquired by Genzyme Corporation

  • 1984

    Novel substrate technology developed for direct measurement of amylase and marketed worldwide

  • 1990

    Launch of our first recombinant enzyme - Recombinant Cholesterol Oxidase

  • 1991

    Acquired the diagnostic enzyme products business of Genencor International

  • 1992


    Research and Development Facility opened in West Malling, Kent, UK - Home of our International Commercial operations and Research & Development



    Launch of first liquid stable amylase technology based on a novel chromogenic substrate CNPG₃

  • 1993

    cGMP hyaluronic acid manufacturing starts at Springfield Mill, Maidstone, UK

  • 1994


    Genzyme wins Queen’s Award for export

  • 1995


    Genzyme in Kent achieves ISO9001 and ISO13485 accreditation

  • 1997


    New state-of-the-art manufacturing facility opened in Maidstone, UK - relocated from Springfield Mill site and named after the founder of Genzyme, Henry Blair

  • 1998

    A major diagnostics organization outsources its manufacturing to the Kent facility

  • 2000

    Production of antibodies begins in our newly commissioned cell culture facility

  • 2004

    Exclusive distribution of Asahi Enzymes initiated for the commercialization of their diagnostic enzyme range outside of Japan

  • 2006

    Our GMP high purity enzyme manufacturing facility opened;  first product for biotherapeutic use successfully received by our partner

  • 2009


    Achieved accreditation of ISO14001:2004 and OHSAS18001:2007

  • 2011

    Sekisui Chemical Co. Ltd. acquires Genzyme Diagnostics leading to the creation of Sekisui Diagnostics



    Launch of first enzyme specifically designed for use in Biosensor applications

  • 2012


    Launch of Sekisui Enzymes – the face of the critical raw materials business unit of Sekisui Diagnostics